Literature DB >> 24590407

Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis.

Song Tan1, Deren Wang, Ming Liu, Shihong Zhang, Bo Wu, Bian Liu.   

Abstract

Few prospective studies have examined the frequency, predictors and long-term outcomes of spontaneous hemorrhagic transformation (HT) in patients with ischemic stroke not receiving thrombolytic treatment. We prospectively enrolled a consecutive cohort of 407 patients with ischemic stroke who were admitted within one month of stroke onset. In patients who developed spontaneous HT, the area of the infarct and HT were examined by computed tomography (CT) or magnetic resonance imaging (MRI). Univariate analysis was used to correlate clinical characteristics with appearance of HT, then multivariate logistical regression was used to identify independent predictors of spontaneous HT and factors that predict 3-month prognosis of ischemic stroke. Spontaneous HT was observed in 50 patients (12.3 %), comprising 33 cases (66 %) of hemorrhagic infarction, 17 (34 %) of parenchymal hematoma, 32 (64 %) of non-symptomatic HT, and 18 (36 %) of symptomatic HT. In 40 % of HT cases, the condition was detected by CT or MRI within 4-7 days of symptom onset. Multivariate logistic regression identified atrial fibrillation (OR 4.88, 95 % CI 1.83-13.00, P = 0.002) and infarct area (OR 4.48, 95 % CI 1.85-10.85, P = 0.001) as independent predictors of HT in ischemic stroke. Multivariate analysis also found that spontaneous HT was not independently associated with a worse 3-month prognosis for ischemic stroke (OR 1.59, 95 % CI 0.38-6.69, P = 0.527). Spontaneous HT occurred in 12.3 % of our patients with ischemic stroke, and atrial fibrillation and large infarct area were independent predictors. Spontaneous HT was not an independent predictor of a worse 3-month prognosis for ischemic stroke.

Entities:  

Mesh:

Year:  2014        PMID: 24590407     DOI: 10.1007/s00415-014-7297-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  The clinical spectrum of hemorrhagic infarction.

Authors:  B R Ott; A Zamani; J Kleefield; H H Funkenstein
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

2.  The clinical meaning of Rankin 'handicap' grades after stroke.

Authors:  R de Haan; M Limburg; P Bossuyt; J van der Meulen; N Aaronson
Journal:  Stroke       Date:  1995-11       Impact factor: 7.914

3.  Blood pressure and clinical outcomes in the International Stroke Trial.

Authors:  Jo Leonardi-Bee; Philip M W Bath; Stephen J Phillips; Peter A G Sandercock
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  [Analysis on the clinical characteristics and related risk factors of patients with hemorrhagic transformation after cerebral infarction].

Authors:  Jia-jun Chen; Shuang Zhang; Yun-hua Zhao; Xi-ya Jin; Yuan-bing Li; Li-hong Huang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-11

5.  The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke.

Authors:  Youngchai Ko; Jung Hyun Park; Mi Hwa Yang; Sang-Bae Ko; Moon-Ku Han; Chang Wan Oh; Jisung Lee; Juneyoung Lee; Hee-Joon Bae
Journal:  Stroke       Date:  2010-10-14       Impact factor: 7.914

6.  CT-detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift.

Authors:  J Lodder
Journal:  Acta Neurol Scand       Date:  1984-11       Impact factor: 3.209

7.  Frequency and determinants for hemorrhagic transformation of cerebral infarction.

Authors:  Valeria Terruso; Marco D'Amelio; Norma Di Benedetto; Innocenzo Lupo; Valentina Saia; Giorgia Famoso; Maria Antonietta Mazzola; Paolo Aridon; Caterina Sarno; Paolo Ragonese; Giovanni Savettieri
Journal:  Neuroepidemiology       Date:  2009-07-27       Impact factor: 3.282

8.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

9.  Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis.

Authors:  Maarten G Lansberg; Erich Bluhmki; Vincent N Thijs
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

10.  U-shaped relationship between mortality and admission blood pressure in patients with acute stroke.

Authors:  K N Vemmos; G Tsivgoulis; K Spengos; N Zakopoulos; A Synetos; E Manios; P Konstantopoulou; M Mavrikakis
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

View more
  20 in total

Review 1.  Anticoagulation Resumption After Stroke from Atrial Fibrillation.

Authors:  Brian Mac Grory; Shane Flood; Matthew Schrag; Maurizio Paciaroni; Shadi Yaghi
Journal:  Curr Atheroscler Rep       Date:  2019-05-20       Impact factor: 5.113

Review 2.  Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.

Authors:  Joshua A Stone; Joshua Z Willey; Salah Keyrouz; James Butera; Ryan A McTaggart; Shawna Cutting; Brian Silver; Bradford Thompson; Karen L Furie; Shadi Yaghi
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

Review 3.  Hemorrhagic transformation after cerebral infarction: current concepts and challenges.

Authors:  Jie Zhang; Yi Yang; Huijie Sun; Yingqi Xing
Journal:  Ann Transl Med       Date:  2014-08

Review 4.  Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.

Authors:  Chengli Liu; Jie Xie; Shanshan Sun; Hui Li; Tianyu Li; Chao Jiang; Xuemei Chen; Junmin Wang; Anh Le; Jiarui Wang; Zhanfei Li; Jian Wang; Wei Wang
Journal:  Cell Mol Neurobiol       Date:  2020-10-30       Impact factor: 5.046

5.  Radiological predictors of hemorrhagic transformation after acute ischemic stroke: An evidence-based analysis.

Authors:  Nada Elsaid; Wessam Mustafa; Ahmed Saied
Journal:  Neuroradiol J       Date:  2020-01-23

6.  Prediction of Hemorrhage after Successful Recanalization in Patients with Acute Ischemic Stroke: Improved Risk Stratification Using Dual-Energy CT Parenchymal Iodine Concentration Ratio Relative to the Superior Sagittal Sinus.

Authors:  D Byrne; J P Walsh; H Schmiedeskamp; F Settecase; M K S Heran; B Niu; A K Salmeen; B Rohr; T S Field; N Murray; A Rohr
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-02       Impact factor: 3.825

7.  Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke : Posterior ischemic stroke and hemorrhagic transformation.

Authors:  Francesca Valentino; Luana Gentile; Valeria Terruso; Sergio Mastrilli; Paolo Aridon; Paolo Ragonese; Caterina Sarno; Giovanni Savettieri; Marco D'Amelio
Journal:  BMC Res Notes       Date:  2017-11-13

8.  Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China.

Authors:  Weihua Jia; Xiaoling Liao; Yuesong Pan; Yilong Wang; Tao Cui; Lichun Zhou; Yongjun Wang
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

9.  Accuracy of Non-Enhanced CT in Detecting Early Ischemic Edema Using Frequency Selective Non-Linear Blending.

Authors:  Georg Bier; Malte N Bongers; Hendrik Ditt; Benjamin Bender; Ulrike Ernemann; Marius Horger
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Association of Elevated High Sensitivity Cardiac Troponin T(hs-cTnT) Levels with Hemorrhagic Transformation and 3-Month Mortality in Acute Ischemic Stroke Patients with Rheumatic Heart Disease in China.

Authors:  Junfeng Liu; Deren Wang; Yao Xiong; Bian Liu; Zilong Hao; Wendan Tao; Ming Liu
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.